Mirum Pharmaceuticals, Inc. - common stock (MIRM) Social Stream
Mirum Pharmaceuticals Inc (MIRM) Price Targets From Analysts
Use the tables below to see what analysts covering Mirum Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 122 days, MIRM's average price target has gone up $1.54.
MIRM reports an average of 178.48% for its upside potential over the past 18 months.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MIRM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 31 days, MIRM's average broker recommendation rating improved by 0.33.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The upside potential (average analyst target price relative to current price) of MIRM is higher than 93.79% of all US stocks.
- MIRM has a lower variance in analysts' estimates than 7.08% of stocks in the small market cap category.
- MIRM has a greater average analyst price target than 89.35% of stocks in the small market cap category.
- MIRM has a higher number of analysts covering the stock than 71.36% of stocks in the small market cap category.
Is MIRM a Buy, Hold or Sell? See the POWR Ratings now!